KDR and Behcet disease: Among them, MPO and rutaecarpine, PPARG and worenine, NOS3 and β-sitosterol, epiberberin, MMP3 and LAN, MMP9 and aureusidin, IL-17A and anemoside B4, KDR, and epiberberine in BD the possible therapeutic role in the treatment of UC was mapped for their molecular docking results (Fig. 6).